The J.M. Smucker Company
SJM
$120.02
+0.16%
The J.M. Smucker Company is a packaged food manufacturer whose portfolio spans retail coffee (Folgers, Dunkin', Cafe Bustelo), pet foods (Milk-Bone, Meow Mix), frozen handhelds and spreads (Jif, Smucker's, Uncrustables), and sweet baked snacks following the Hostess Brands acquisition, sold primarily through U.S. retail channels with additional away-from-home and international exposure. It is a scaled, brand-owning consumer staples operator rather than a growth disruptor, competing on shelf presence, brand equity, and pricing power in mature categories. The current investor debate centers on whether coffee pricing actions can offset volume softness and whether the Hostess-driven snacking pivot can revive growth, set against a backdrop of elevated input costs and a weak forward sales outlook flagged after the June 2026 earnings beat. Sentiment has been further complicated by a large goodwill/impairment-driven loss in fiscal Q3 2026 that distorted trailing profitability metrics, leaving investors to focus on adjusted earnings power and cash generation.…
SJM
The J.M. Smucker Company
$120.02
Related headlines
Investment Opinion: Should I buy SJM Today?
We assign a Hold rating with a positive bias. The core thesis is that SJM offers a compelling value proposition with a 4.44% dividend yield and a forward PE of 10.97x, but near-term growth headwinds and execution risks warrant caution. The analyst consensus is Buy with an average target of $142.13, implying 18.6% upside, but the wide target range ($120–$157) reflects divergent views on the company's ability to reignite growth.
Supporting evidence includes: 1) Revenue growth of 5.02% year-over-year in Q1 2027, driven by coffee pricing; 2) Gross margin expansion to 44.14% from 35.39% in Q3 2026; 3) Free cash flow of $1.588 billion, yielding ~15%; 4) A dividend yield of 4.44% that is well covered by cash flow. The forward PE of 10.97x is a steep discount to the sector's 15–20x, and the PEG ratio of 0.85 suggests undervaluation relative to growth. However, the weak forward sales outlook and high leverage (debt-to-equity of 1.28) are concerns.
Key risks that could invalidate the thesis include: 1) A decline in coffee prices that erodes pricing gains; 2) Further impairment charges on the Hostess acquisition; 3) A deterioration in free cash flow that threatens the dividend. The rating would upgrade to Buy if the forward PE compresses below 10x or if revenue growth accelerates above 6%. It would downgrade to Sell if revenue growth turns negative or if the dividend coverage ratio falls below 1.5x. Relative to its own history, the stock is fairly valued, but relative to peers, it is undervalued.
Sign up to view all
SJM 12-Month Price Forecast
SJM presents a balanced risk/reward profile. The valuation is undemanding, and cash flow is robust, but growth is sluggish and leverage is high. The analyst consensus is bullish, yet the wide target range and recent underperformance suggest caution. We would upgrade to bullish if revenue growth accelerates above 5% and margins expand further; we would downgrade to bearish if free cash flow declines or impairments recur. The stock is suitable for income-oriented investors with a medium-term horizon.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The J.M. Smucker Company's 12-month outlook, with a consensus price target around $142.13 and implied upside of +18.4% versus the current price.
Average Target
$142.13
0 analysts
Implied Upside
+18.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$120 - $157
Analyst target range
Coverage is solid with 16 analysts, and the consensus recommendation is Buy with a recommendation mean of 2.11 (where lower is more bullish on a 1–5 scale). The average target price of $142.13 implies roughly 18.6% upside from the current price of $119.83, and the consensus leans bullish — the institutional ratings list shows predominantly Outperform/Overweight/Buy actions from firms including RBC Capital, Wells Fargo, Evercore ISI, Bernstein, UBS, Jefferies, and JP Morgan, with only Barclays (Equal Weight) and TD Cowen (Hold) sitting neutral. Notably, the August 2026 ratings actions were almost entirely reiterations rather than upgrades or downgrades, indicating analysts are holding steady convictions after the Q4 earnings report rather than repositioning. The target range is wide, from a low of $120.00 to a high of $157.00 — a spread of $37, or about 31% of the low target — which signals meaningful disagreement about the company's trajectory. The low target of $120.00 is essentially the current price, implying that the most cautious analyst sees no upside and prices in continued volume weakness, margin pressure from coffee costs, and a stalled Hostess integration. The high target of $157.00 (31% above current) would require multiple expansion toward peer-group levels plus successful execution on coffee pricing, snack growth, and debt reduction, effectively assuming the market re-rates SJM as a normal branded-foods compounder. The forward EPS estimates are tight — $11.37 low to $12.29 high around a $12.08 average — showing analysts agree on near-term earnings but diverge sharply on the multiple the market should pay, which is the crux of the valuation debate. With the stock trading below the average target but at the low end of the target range, the risk/reward skews modestly positive, though the wide spread and the recent 1-month underperformance suggest conviction is not yet strong enough to drive a near-term re-rating.
Bulls vs Bears: SJM Investment Factors
The bull case rests on deep valuation discounts, robust cash flow, and analyst optimism, while the bear case highlights weak forward sales, high leverage, and commodity concentration. Currently, the bear evidence appears slightly stronger given the recent underperformance and management's cautious outlook, but the bull case is supported by tangible cash generation and a defensive profile. The single most important tension is whether coffee pricing actions can sustainably offset volume declines and drive margin expansion without further impairments. Resolution of this debate—likely revealed in upcoming quarterly results—will determine whether the stock re-rates toward peer multiples or remains range-bound.
Bullish
- Deep discount to staples peers: SJM trades at a forward PE of 10.97x versus the typical 15–20x for packaged-food peers, a roughly 30–45% earnings discount. The PS ratio of 1.16x is also well below the 1.5–2.5x sector norm, implying the market is pricing in persistent skepticism that may prove overdone.
- Strong free cash flow and dividend coverage: Trailing free cash flow of $1.588 billion equates to a roughly 15% FCF yield on the $10.46 billion market cap, easily covering the ~$117 million quarterly dividend. The 4.44% dividend yield is well supported by cash generation, providing a valuation floor.
- Analyst consensus sees 18.6% upside: With 16 analysts covering the stock, the consensus recommendation is Buy (mean 2.11) and the average target price of $142.13 implies 18.6% upside from $119.83. The high target of $157.00 suggests 31% upside if execution improves.
- Margin recovery underway: Gross margin expanded to 44.14% in fiscal Q1 2027 from 38.01% in Q4 2026 and 35.39% in Q3 2026, driven by coffee pricing and favorable mix. Operating margin of 23.05% in the latest quarter shows underlying profitability remains solid despite prior impairment charges.
Bearish
- Weak forward sales outlook: Management flagged a weak sales outlook for the coming year after the June 2026 earnings beat, with estimated revenue of $9.27 billion versus trailing twelve-month revenue of approximately $9.0 billion. This suggests growth may stall as pricing actions fail to offset volume softness.
- Elevated leverage and weak liquidity: Debt-to-equity of 1.28 and total debt-to-capitalization of 54.5% are high for a staples company, while the current ratio of 0.777 indicates current liabilities exceed current assets. This limits financial flexibility and increases risk if cash flows deteriorate.
- Coffee concentration risk: U.S. Retail Coffee represents roughly 41% of reported segment revenue at $916.8 million, concentrating growth risk in a single commodity-sensitive category. Any reversal in coffee prices or volume declines could disproportionately impact overall results.
- Impairment-driven earnings distortion: A $1.07 billion impairment charge in fiscal Q3 2026 caused a net loss of $724.2 million, and a similar charge in Q4 2025 led to a $729.0 million loss. These charges have distorted trailing EPS to -$0.013 and net margin to -1.53%, raising questions about asset valuations.
SJM Technical Analysis
SJM is in a sustained recovery uptrend, with the current price of $119.83 up 13.99% over the past year and 24.01% year-to-date, though it remains 11.8% below its 52-week high of $135.89 and 35.8% above its 52-week low of $88.25. At roughly 65% of its 52-week range, the stock sits in the upper-middle of its band — neither a momentum breakout nor a distressed falling knife — suggesting a market that has re-rated the shares off the lows but still demands proof of durable growth before retesting highs. The 6-month gain of 31.81% versus a 1-year gain of 13.99% confirms the bulk of the advance occurred recently, a classic recovery profile rather than a multi-year compounding trend. Recent momentum has cooled: the 1-month change of -2.82% contrasts with the 3-month gain of 7.37% and the 6-month gain of 31.81%, indicating deceleration after the late-August peak near $132. This divergence — a strong medium-term trend but a negative last month — signals a consolidation or pullback phase rather than a trend reversal, especially since the stock remains well above its 52-week low. Relative strength tells the same story: SJM outperformed SPY by 17.22 percentage points over 6 months and 4.24 points over 3 months, but lagged by 4.94 points over the past month as SPY gained 2.12% while SJM declined, a rotation out of the recent winner. Key resistance sits at the 52-week high of $135.89, with the August swing high around $132 acting as the nearer ceiling; a breakout above that zone would confirm renewed institutional accumulation and open a path toward the highs. Support is anchored at the 52-week low of $88.25, with intermediate support likely near the $110–$115 area where the stock consolidated in July and again in early October. The beta of 0.266 is exceptionally low — roughly 73% less volatile than the market — meaning SJM offers defensive positioning and smaller drawdowns (max drawdown of -22.82% over the period) but also muted upside participation, which matters for portfolio sizing and for interpreting the modest 0.35% single-day move.
Beta
0.27
0.27x market volatility
Max Drawdown
-22.8%
Largest decline past year
52-Week Range
$88-$136
Price range past year
Annual Return
+14.6%
Cumulative gain past year
| Period | SJM Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | +1.8% |
| 3m | +10.3% | +3.5% |
| 6m | +28.4% | +11.2% |
| 1y | +14.6% | +19.1% |
| ytd | +24.2% | +14.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SJM Fundamental Analysis
Revenue is growing modestly but steadily, with the most recent quarter (fiscal Q1 2027, ended 2026-07-31) delivering $2.219 billion, up 5.02% year-over-year from $2.113 billion in the prior-year quarter. The multi-quarter trend is stable rather than accelerating: quarterly revenue has ranged from $2.113 billion to $2.339 billion over the past five reported periods, with the Q1 2027 figure slightly below the $2.268 billion reported in Q4 2026 and the $2.339 billion in Q3 2026. Segment data shows U.S. Retail Coffee as the largest contributor at $916.8 million, followed by U.S. Retail Consumer Foods at $499.3 million, U.S. Retail Pet Foods at $371.7 million, and Sweet Baked Snacks at $236.5 million — meaning coffee alone is roughly 41% of the reported segment total, concentrating growth risk in a single commodity-sensitive category. The 5.02% growth rate is respectable for packaged foods but reflects pricing more than volume, and the weak forward sales outlook noted after Q4 earnings suggests the trajectory may moderate. Profitability is solid on an operating basis but distorted by non-cash charges: the latest quarter posted net income of $324.3 million on a 14.61% net margin, with gross profit of $979.6 million and a 44.14% gross margin, while operating income of $511.6 million equated to a 23.05% operating margin. However, the trailing picture is marred by the fiscal Q3 2026 loss of $724.2 million (driven by a $1.07 billion other-expense/impairment charge) and the fiscal Q4 2025 loss of $729.0 million, which together produce the negative trailing EPS of -$0.013 and net margin of -1.53%. Gross margin has been volatile — 44.14% in Q1 2027 versus 38.01% in Q4 2026 and 35.39% in Q3 2026 — with the latest quarter showing meaningful expansion, likely aided by coffee pricing and favorable mix, though the sustainability of that 44% level is the key question given commodity swings. The balance sheet carries meaningful leverage: debt-to-equity of 1.279, a current ratio of just 0.777 (below 1.0, indicating current liabilities exceed current assets), and total debt-to-capitalization of 54.5% as of the latest historical ratio. Cash generation remains the strongest part of the story, with trailing free cash flow of $1.588 billion and quarterly FCF of $337.3 million in Q1 2027, $483.9 million in Q4 2026, and $487.0 million in Q3 2026 — comfortably covering the ~$117 million quarterly dividend and capital expenditure of $88.4 million. The FCF yield of roughly 15% on the $10.46 billion market cap is high for a staples name, and the dividend yield of 4.44% is well covered by cash flow, though the negative payout ratio of -3.35 reflects the trailing GAAP loss rather than a cash-flow problem. ROE of -2.50% and ROA of 6.26% underscore that reported returns are temporarily depressed by impairments, not by operational deterioration.
Quarterly Revenue
$2.2B
2026-07
Revenue YoY Growth
+5.0%
YoY Comparison
Gross Margin
44.1%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SJM Overvalued?
Because trailing net income is negative (EPS of -$0.013, net margin of -1.53%), the trailing PE of -75.41 is meaningless and I am leading with the forward PE of 10.97x, which is the appropriate metric given the company's positive forward earnings estimate of $12.08 per share. The gap between the unusable trailing multiple and the 10.97x forward multiple implies the market expects a sharp earnings normalization as impairment charges roll off, and the forward PE sits well below the sector-typical mid-to-high teens for packaged foods, suggesting the stock is priced for skepticism. The PEG ratio of 0.85 (below 1.0) and PS ratio of 1.16 further indicate the shares are not expensive relative to expected growth, though the EV/EBITDA of 19.97x looks rich and reflects the depressed trailing EBITDA base. Against packaged-food peers, SJM's forward PE of 10.97x and PS of 1.16x screen at a discount to the broader Consumer Defensive sector, where stable branded-food names often trade at 15–20x forward earnings and 1.5–2.5x sales — implying a roughly 30–45% discount on earnings and a similar discount on sales. That discount is partly justified by the leverage (debt-to-equity of 1.28 versus typically lower peer levels), the coffee commodity exposure, and the weak forward sales outlook, but the 4.44% dividend yield and 15% FCF yield provide a valuation floor that limits downside. The PB ratio of 1.89 is modest in absolute terms, though the historical data shows PB has ranged from about 1.58 to 2.27 over the past several years, placing the current 1.89 near the middle of its own band. Historical PE ratios are noisy due to the loss quarters, but the profitable quarters have traded between roughly 6.7x and 11.5x, and the current forward PE of 10.97x sits near the upper end of that profitable-quarter range — meaning the market has already re-rated the stock from the deep-value levels seen in 2026 and is now pricing in a more normal earnings environment. The PS ratio of 1.16 is near the low end of the historical range (which has run from about 1.16 to 8.55 over the years, though the high end reflects a different share count and price era), suggesting sales-based valuation remains undemanding.
PE
-75.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 7x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company carries debt-to-equity of 1.28 and a current ratio of 0.777, indicating limited short-term liquidity. Although free cash flow of $1.588 billion comfortably covers the dividend, any operational setback could strain the balance sheet. Additionally, the concentration in coffee (41% of segment revenue) exposes SJM to commodity price volatility and potential volume declines if pricing actions fail to stick. The recent impairment charges totaling over $1.8 billion in the past two fiscal years highlight the risk of further write-downs if the Hostess acquisition underperforms.
Market and competitive risks are moderate. The stock's low beta of 0.266 provides defensive characteristics, but it also limits upside participation in bull markets. Valuation compression risk exists if the company fails to meet earnings expectations; the forward PE of 10.97x is already a discount, but it could contract further if growth stalls. Competitive pressures in packaged foods are intense, with private-label brands gaining share amid inflation. Recent news of Conagra's struggles (CEO replacement, 52-week low) underscores sector-wide challenges that could spill over to SJM.
In a worst-case scenario, a combination of volume declines, coffee cost deflation, and failed integration of Hostess could lead to earnings misses and multiple compression. The 52-week low of $88.25 represents a 26.4% downside from the current price of $119.83. If the bear case materializes, the stock could retest that low, implying a loss of over 26%. The analyst low target of $120.00 offers no downside protection, but the wide target range ($120–$157) signals significant uncertainty. A more severe scenario, such as a recession or a major impairment, could push the stock below $88, but that is not our base case.
FAQ
The key risks include: 1) Financial risk: high debt-to-equity of 1.28 and a current ratio of 0.777, which could strain liquidity if cash flows decline. 2) Operational risk: concentration in coffee (41% of segment revenue) exposes the company to commodity price volatility and volume declines. 3) Market risk: the stock's low beta (0.266) limits upside but also means it may underperform in bull markets. 4) Company-specific risk: further impairment charges on the Hostess acquisition could erode investor confidence. These risks are ranked from highest to lowest severity, with financial and operational risks being the most immediate.
Our 12-month forecast has three scenarios: bull case (25% probability) with a target range of $142–$157, driven by successful coffee pricing and Hostess synergies; base case (55% probability) with a target range of $120–$142, assuming steady execution and modest growth; and bear case (20% probability) with a target range of $88–$120, triggered by volume declines and further impairments. The base case is most likely, supported by the analyst average target of $142.13 and current valuation multiples. Key assumptions include revenue growth of 2–3% and stable gross margins above 40%.
SJM appears undervalued relative to its peers. Its forward PE of 10.97x is a significant discount to the 15–20x typical for packaged-food companies, and its PS ratio of 1.16x is below the sector's 1.5–2.5x. The PEG ratio of 0.85 suggests the stock is cheap relative to expected growth. However, the EV/EBITDA of 19.97x is elevated due to depressed trailing EBITDA. The market is pricing in skepticism about future growth, but the 4.44% dividend yield and 15% free cash flow yield provide a valuation floor. Overall, the stock is undervalued on earnings and sales metrics.
SJM may be a good buy for income-focused investors, given its 4.44% dividend yield and forward PE of 10.97x, which is well below the sector average. The analyst consensus target of $142.13 implies 18.6% upside, but the weak forward sales outlook and high leverage (debt-to-equity 1.28) present risks. The stock's low beta of 0.266 makes it defensive, but growth is modest. It is most suitable for those seeking stable dividends and willing to accept limited capital appreciation. A more favorable entry point would be near the 52-week low of $88.25.
SJM is more suitable for long-term investment, given its defensive characteristics, low beta (0.266), and reliable dividend (4.44% yield). The company operates in mature categories with stable demand, making it a classic income play. Short-term trading is less attractive due to muted volatility and the recent consolidation phase. Earnings visibility is moderate, with analysts estimating EPS of $12.08 for the next fiscal year. A minimum holding period of 2–3 years is recommended to capture dividend income and potential multiple expansion. The stock is not suited for aggressive growth investors.